Sculptor Capital’s Insys Therapeutics, Inc. INSY Stock Holding History

Sculptor Capital’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-51,100	Closed	-$236K	–	324
2019 Q1	$236K	Buy	+51,100	New	+$242K	﹤0.01%	207
2017 Q4	–	Sell	-96,800	Closed	-$860K	–	267
2017 Q3	$860K	Buy	+96,800	New	+$999K	﹤0.01%	265
2016 Q4	–	Sell	-78,500	Closed	-$926K	–	399
2016 Q3	$926K	Buy	+78,500	New	+$1.19M	0.01%	245

Other funds holding INSY

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

KBC Group Brussels, Belgium $39.9B AUM 29.7% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return

Sculptor Capital's INSY Position: Q2 2019 in Review

Sculptor Capital sold out of Insys Therapeutics, Inc. (INSY) in Q2 2019, closing a stake of 51,100 shares — an estimated $236K sold.

Sculptor Capital first reported a position in INSY in Q3 2016 and held it in 3 quarters. The position peaked at $875K in Q3 2016. 16 funds tracked by Wall St. Rank hold INSY as of Q2 2019.

Sculptor Capital reported no remaining Insys Therapeutics, Inc. position as of Q2 2019 after selling out during the quarter.
Sculptor Capital sold 51,100 Insys Therapeutics, Inc. shares in Q2 2019, an estimated $236K.
Sculptor Capital first reported a position in Insys Therapeutics, Inc. in Q3 2016 and held it in 3 quarters.
Sculptor Capital's Insys Therapeutics, Inc. position peaked at $875K in Q3 2016.
16 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2019.

Based on Sculptor Capital's 13F filing for Q2 2019, filed 14 Aug 2019.